Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

about

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

Item

http://www.wikidata.org/entity/Q38850355

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

@en

type

Item

label

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

@en

prefLabel

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

@en

P1476

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

@en

P2093

F Piscione

http://www.w3.org/2001/XMLSchema#string

G De Luca

http://www.w3.org/2001/XMLSchema#string

G Galasso

http://www.w3.org/2001/XMLSchema#string

M Mirra

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Bivalirudin for patients with acute coronary syndromes

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Bivalirudin during primary PCI in acute myocardial infarction

Clinical pharmacology of bivalirudin.

Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention.

P304

54-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27326396

http://www.w3.org/2001/XMLSchema#string

P932

4912339

http://www.w3.org/2001/XMLSchema#string